SZSE Ticker: 300026

Tianjin Chase Sun Pharmaceutical Co., Ltd.

天津红日药业股份有限公司

红日药业

CHASE SUN PHARM.

Listing Date: 2009-10-30

Board: GEM

Industry Classification: Manufacturing

Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated

Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated

The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value

The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value_ Oriental Fortune Net

burst! A plane caught fire at Chongqing Airport, and the injured have been sent to the hospital for treatment! The Polish embassy in Russia was splashed with red paint, and A-shares welcomed super support. Why not fear the plunge in US stocks

Why A-Shares Welcome Super Support

Sector Changes The New Crown Epidemic Has Not Yet The Biggest Mainline Of The Pharmaceutical Sector, The New Crown Treatment Concept Stock Strengthens Again_Stock News_Market Gold Online

Watching the market: Hongtao shares and other 6 stocks stopped in seconds CFi.CN Zhongcai Network

[News] Red Sun Pharmaceutical Announces 2021 Annual Dividend Implementation Plan CFi.CN

Hongri Pharmaceutical (300026.SZ) 2021 annual equity distribution 10 distributions of 0.4 yuan The equity registration date is May 18_Stock Information_Market Gold Online

2.389 billion yuan of main funds withdraw from the pharmaceutical and biological sector today_ Oriental Fortune Net

Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains

The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan.

China Universal CSI Traditional Chinese Medicine Index (LOF) C Net Value Up 3.20% China Universal

China Universal China Securities Traditional Chinese Medicine Index (LOF) A Net Value Up 3.20% China Universal

Medicine: The new crown nucleic acid test is normalized, the economy is stabilized, and the business recovery of the leading companies in the high-prosperity track is optimistic after the epidemic period – yqqlm

What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code)

China Universal China Securities Traditional Chinese Medicine Index (LOF) A Net Value Up 3.63% China Universal

China Universal CSI Traditional Chinese Medicine Index (LOF) C Net Value Up 3.63% China Universal

The medical and biological industry funds flow to the daily on April 28_ Oriental Fortune Net

The net outflow of the pharmaceutical and biological industry today is 1.164 billion yuan, and the net outflow of 5 shares exceeds 100 million yuan_Oriental Fortune Net

Want to see more data? Registered subscribers can see all the data.